Jeff Kindler

Jeff Kindler is a Venture Partner at Lux Capital and a senior advisor to Paragon Pharmaceuticals. Mr. Kindler was formerly the Chairman and CEO of Pfizer, the world’s largest research-based biopharmaceutical company. He also serves on the boards of AgaMatrix; Intrexon; Sheridan Healthcare, a provider of healthcare solutions to physicians, hospitals, and outpatient centers; PPD, a global contract drug discovery, and development research organization; Tufts University; and the National Center on Addiction and Substance Abuse at Columbia University.